Cancer News and Research

Latest Cancer News and Research

Body fat protein adiponectin plays role in tumour growth

Scientists have discovered how low levels of a protein hormone found in body fat, plays a crucial role in tumour growth and spread. Their findings are published in a paper in the British Journal of Cancer.

31 Jan 2008

Viruses for a healthy pregnancy

Sequences of DNA in the human genome that originated from ancient viral infections have some surprising effects on our bodies and are even essential for a healthy pregnancy, according to an article in the February issue of Microbiology Today.

31 Jan 2008

Researchers find no link between prostate cancer risk and blood levels of testosterone or estrogen

Sex hormones circulating in the blood do not appear to be associated with prostate cancer risk, according to data from 18 prior studies.

31 Jan 2008

Physician characteristics are associated with quality of cancer care

Whether a woman receives radiation after breast cancer surgery may be associated with certain characteristics of her surgeon, including sex and medical training, according to a study published online January 29 in the Journal of the National Cancer Institute .

31 Jan 2008

Study confirms safety of BrachySil for treatment of inoperable pancreatic cancer

The results of a Phase IIa clinical trial of BrachySil for the treatment of advanced, inoperable pancreatic cancer were presented at American Society of Clinical Oncolgy-GI (ASCO-GI) this weekend in a poster presented by Dr. Paul Ross, Chief Investigator in the study and Consultant Medical Oncologist at Guy's and St. Thomas' NHS Foundation Trust.

30 Jan 2008

Well-funded tobacco control programs reduce number of smokers by millions

The following is a statement by William V. Corr, Executive Directior of the Campaign for Tobacco-Free Kids:

30 Jan 2008

Leukemia relapse stems from DNA repair function loss

A University of Kentucky research team reports that loss of an important DNA repair function, called DNA mismatch repair (MMR), is responsible for refractory/relapsed Acute Myeloid Leukemia (AML).

30 Jan 2008

Kidney cancer drug attacks a major type of acute myeloid leukemia

A drug used to treat kidney cancer also targets a genetic mutation active in about one third of patients with acute myeloid leukemia (AML), the most common and lethal form of adult leukemia, researchers at The University of Texas M. D. Anderson Cancer Center report in the Jan. 29 edition of the Journal of the National Cancer Institute.

30 Jan 2008

Link between microRNA expression patterns and poor outcomes for colon cancer

Preliminary research has found an association between certain microRNA expression patterns and poor survival and treatment outcomes for colon cancer, according to a study in the January 30 issue of JAMA: The Journal of the American Medical Association.

30 Jan 2008

Digital mammography may be a better screening option than film mammography

For some women, digital mammography may be a better screening option than film mammography, according to newly published results from a national study led by a University of North Carolina at Chapel Hill researcher.

30 Jan 2008

Cell signaling in cervical cancer; gene variant impairs glycogen synthesis

The March of Dimes and seven former directors of the U.S. Centers for Disease Control and Prevention (CDC) today urged parents not to be frightened of childhood vaccines by the suggestion in an upcoming episode of the ABC-TV drama, "Eli Stone" that the mercury-based preservative thimerosal -- which is no longer used in vaccines may lead to autism.

30 Jan 2008

Researchers can now determine when a human was born by radiocarbon dating of the human eye lens

Using the radiocarbon dating method and special proteins in the lens of the eye, researchers at the University of Copenhagen and Aarhus can now establish, with relatively high precision, when a person was born.

30 Jan 2008

New nanomedicine research for prostate cancer

The Prostate Cancer Foundation, largely through the generosity of David H. Koch, has given $5 million to four institutions, including Weill Cornell Medical College, to support novel research in prostate cancer. The gift is one of the largest-ever individual donations for prostate cancer research.

29 Jan 2008

New target found for asthma

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma -- pointing to a potential new target for treatment against the illness.

29 Jan 2008

Discovery of novel molecular pattern linked to colon cancer prognosis

An international research team has identified a link between the expression patterns of a class of molecules called microRNAs and how a patient's colon cancer may progress.

29 Jan 2008

Collaboration to improve the UK's health

A collaboration between the Universities of Bristol, Cardiff and Swansea has been awarded £5 million by the UK Clinical Research Collaboration (UKCRC) to establish a Centre of Excellence for research into public health.

29 Jan 2008

Smaller pancreatic tumors greatly increase survival odds

The odds of surviving cancer of the pancreas increase dramatically for patients whose tumors are smallest, according to a new study by researchers at Saint Louis University and the M.D. Anderson Cancer Center in Houston - the first study to specifically evaluate the link between tumor size and survival rates for one of the most common and deadly cancers.

28 Jan 2008

The contraceptive pill gives long-lasting protection against ovarian cancer

The contraceptive Pill gives women substantial and long-lasting protection against ovarian cancer, according to a new report by Cancer Research UK scientists in The Lancet.

28 Jan 2008

Researchers unravel mystery of cell division

Experts in mitosis (cell division) at the University of Virginia Health System have made discoveries that explain how one protein the kinase Aurora B could have such a large role in guiding and policing the process of cell division.

25 Jan 2008

M. D. Anderson, AstraZeneca form alliance to advance understanding of cancer-related pain

The University of Texas M. D. Anderson Cancer Center and AstraZeneca (NYSE:AZN) today announced that they will collaborate to help advance understanding of neuropathic pain caused by cancer chemotherapy, a side effect that often limits optimal therapeutic dosing in cancer treatments.

25 Jan 2008